1. Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Issue 10 (2nd October 2016) Authors: DeBoer, Rebecca; Koval, Gregory; Mulkey, Flora; Wetzler, Meir; Devine, Steven; Marcucci, Guido; Stone, Richard M.; Larson, Richard A.; Bloomfield, Clara D.; Geyer, Susan; Mullighan, Charles G.; Stock, Wendy Journal: Leukemia & lymphoma Issue: Volume 57:Issue 10(2016:Oct.) Page Start: 2298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long‐term survival follow‐up from the randomized, phase 3 INO‐VATE study. Issue 14 (28th March 2019) Authors: Kantarjian, Hagop M.; DeAngelo, Daniel J.; Stelljes, Matthias; Liedtke, Michaela; Stock, Wendy; Gökbuget, Nicola; O'Brien, Susan M.; Jabbour, Elias; Wang, Tao; Liang White, Jane; Sleight, Barbara; Vandendries, Erik; Advani, Anjali S. Journal: Cancer Issue: Volume 125:Issue 14(2019) Page Start: 2474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. Issue 10 (October 2017) Authors: Kantarjian, Hagop M; Roboz, Gail J; Kropf, Patricia L; Yee, Karen W L; O'Connell, Casey L; Tibes, Raoul; Walsh, Katherine J; Podoltsev, Nikolai A; Griffiths, Elizabeth A; Jabbour, Elias; Garcia-Manero, Guillermo; Rizzieri, David; Stock, Wendy; Savona, Michael R; Rosenblat, Todd L; Berdeja, Jesus ... Journal: Lancet oncology Issue: Volume 18:Issue 10(2017:Oct.) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia?. Issue 11 (2nd November 2015) Authors: Liu, Hongtao; Stock, Wendy Journal: Leukemia & lymphoma Issue: Volume 56:Issue 11(2015:Nov.) Page Start: 3005 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immune reconstitution after combined haploidentical and umbilical cord blood transplant. Issue 6 (1st June 2013) Authors: Jain, Nitin; Liu, Hongtao; Artz, Andrew S.; Anastasi, John; Odenike, Olatoyosi; Godley, Lucy A.; Joseph, Loren; Marino, Susana; Kline, Justin; Nguyen, Vu; Schouten, Viviane; Kunnavakkam, Rangesh; Larson, Richard A.; Stock, Wendy; Ulaszek, Jodie; Savage, Peter A.; Wickrema, Amittha; van Besien, Koen Journal: Leukemia & lymphoma Issue: Volume 54:Issue 6(2013:Jun.) Page Start: 1242 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Philadelphia chromosome‐like acute lymphocytic leukemia: Perspectives on diagnosis. Issue 4 (4th July 2019) Authors: Prescott, Kevin; Stock, Wendy Journal: Advances in cell and gene therapy Issue: Volume 2:Issue 4(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Incorporating measurable ('minimal') residual disease-directed treatment strategies to optimize outcomes in adults with acute myeloid leukemia. Issue 7 (2nd July 2016) Authors: Pettit, Kristen; Stock, Wendy; Walter, Roland B. Journal: Leukemia & lymphoma Issue: Volume 57:Issue 7(2016:Jul.) Page Start: 1527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance). Issue 1 (January 2020) Authors: Klepin, Heidi D.; Ritchie, Ellen; Major-Elechi, Brittny; Le-Rademacher, Jennifer; Seisler, Drew; Storrick, Libby; Sanford, Ben L.; Marcucci, Guido; Zhao, Weiqiang; Geyer, Susan A.; Ballman, Karla V.; Powell, Bayard L.; Baer, Maria R.; Stock, Wendy; Cohen, Harvey Jay; Stone, Richard M.; Larson, Ri... Journal: Journal of geriatric oncology Issue: Volume 11:Issue 1(2020) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Impact of minimal residual disease status in patients with relapsed/refractory acute lymphoblastic leukemia treated with inotuzumab ozogamicin in the phase III INO-VATE trial. (January 2020) Authors: Jabbour, Elias; Gökbuget, Nicola; Advani, Anjali; Stelljes, Matthias; Stock, Wendy; Liedtke, Michaela; Martinelli, Giovanni; O'Brien, Susan; Wang, Tao; Laird, A. Douglas; Vandendries, Erik; Neuhof, Alexander; Nguyen, Kevin; Dakappagari, Naveen; DeAngelo, Daniel J.; Kantarjian, Hagop Journal: Leukemia research Issue: Volume 88(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Clinical outcomes of IDH2‐mutated advanced‐phase Ph‐negative myeloproliferative neoplasms treated with enasidenib. (1st May 2020) Authors: Patel, Anand A.; Cahill, Kirk; Charnot‐Katsikas, Angella; Liu, Hongtao; Gurbuxani, Sandeep; Thirman, Michael; Kosuri, Satyajit; Artz, Andrew S.; Larson, Richard A.; Stock, Wendy; Segal, Jeremy; Odenike, Olatoyosi Journal: British journal of haematology Issue: Volume 190:Number 1(2020) Page Start: e48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗